ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

SCTL Societal CDMO Inc

1.10
0.00 (0.00%)
2024年4月23日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Societal CDMO Inc SCTL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 1.10 09:00:00
始値 安値 高値 終値 前日終値
1.10 1.10
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0905:05GLOBECoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
2024/4/0823:10BWCoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
2024/3/1206:04EDGAR2Form SC 14D9 - Solicitation, recommendation statements
2024/3/1205:05EDGAR2Form SC TO-T - Tender offer statement by Third Party
2024/3/0707:11EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2024/3/0107:18EDGAR2Form SC14D9C - Written communication relating to third party..
2024/2/2907:27EDGAR2Form SC14D9C - Written communication relating to third party..
2024/2/2907:18EDGAR2Form SC14D9C - Written communication relating to third party..
2024/2/2906:58EDGAR2Form 8-K - Current report
2024/2/2906:29GLOBESocietal CDMO Enters Into Definitive Agreement to be..
2024/2/0121:00GLOBESocietal CDMO and Benuvia Sign Co-Marketing Agreement..
2024/1/0606:05GLOBESocietal CDMO Reports Inducement Grants for New Staff
2023/11/2906:14EDGAR2Form 8-K - Current report
2023/11/0906:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0906:11EDGAR2Form 8-K - Current report
2023/11/0906:05GLOBESocietal CDMO Reports Third Quarter 2023 Financial Results
2023/11/0205:05GLOBESocietal CDMO to Report Financial Results for Third Quarter..
2023/10/0605:05GLOBESocietal CDMO Reports Inducement Grants for New Staff
2023/9/2605:05GLOBESocietal CDMO to Participate in RBC Capital Markets Virtual..
2023/9/2105:10EDGAR2Form 8-K - Current report
2023/9/2105:05GLOBESocietal CDMO Announces Corporate Restructuring
2023/9/0720:00GLOBESocietal CDMO Secures Project Expansion Agreements With..
2023/8/2920:00GLOBESocietal CDMO Announces Closing of $8.3 Million Public..
2023/8/2905:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2905:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2905:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2605:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2605:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/2605:18EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2023/8/2420:30GLOBESocietal CDMO Announces Pricing of $8.3 Million Public..
2023/8/2405:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/2405:13EDGAR2Form 8-K - Current report
2023/8/2405:04GLOBESocietal CDMO Announces Appointment of Matt Arens to Board..
2023/8/2405:04GLOBESocietal CDMO Announces Proposed Public Offering of Common..
2023/8/1506:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1505:28EDGAR2Form 8-K - Current report
2023/8/1505:05GLOBESocietal CDMO Reports Second Quarter 2023 Financial Results
2023/8/0920:00GLOBESocietal CDMO Reschedules Second Quarter 2023 Financial..
2023/8/0804:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/8/0305:05GLOBESocietal CDMO to Report Financial Results for Second Quarter..
2023/7/2620:00GLOBESocietal CDMO Announces Expansion of Controlled Substance..
2023/7/1020:00GLOBESocietal CDMO Selected by Spinnaker Biosciences to Provide..
2023/7/0805:05GLOBESocietal CDMO Reports Inducement Grants for New Staff
2023/6/2920:00GLOBESocietal CDMO Signs Master Service Agreement With..
2023/5/2320:00GLOBESocietal CDMO Enters Agreement With Atossa Therapeutics to..
2023/5/1105:05GLOBESocietal CDMO Reports First Quarter 2023 Financial Results
2023/5/1005:05GLOBESocietal CDMO to Participate in RBC Capital Markets Global..
2023/5/0820:00GLOBESocietal CDMO Selected by Xequel Bio to Provide CDMO..
2023/5/0405:05GLOBESocietal CDMO to Report Financial Results for First Quarter..
2023/5/0319:45GLOBECingulate Announces Successful Transfer of CTx-1301..

最近閲覧した銘柄

Delayed Upgrade Clock